
PWHL selects Seattle for 2nd expansion franchise. Plans to add another 2 by 2026-27, AP source says
Seattle's addition, announced Wednesday, gives the PWHL a strong foothold in the Pacific Northwest and comes a week after the unveiling of the new
team in Vancouver
for the 2025-26 season. The westward move broadens the league's reach across the continent in two markets with a history supporting women's sports and separated by just a three-hour drive.
'Of course the geography makes a ton of sense and I think we have a built-in rivalry here that will just naturally happen,' executive vice president of business operations Amy Scheer told the AP.
'But most importantly is they met all the criteria in terms of what we were looking for,' she added. 'There's just a ton of business reasons to do it. And those are the only things we're focused on.'
The two-team expansion for Season 3 is only the beginning for a league that
launched in January 2024
with five Eastern franchises — Boston, New York, Montreal, Ottawa and Toronto — and one in St. Paul, Minnesota.
The PWHL plans to grow to 10 teams for its 2026-27 season, a person with knowledge of discussions told the AP on the condition of anonymity because the talks are private. The person said the league is accelerating its plans based on the strength of responses and feedback received during its eight-month expansion search in which
the PWHL considered more than 20 markets
.
Scheer didn't entirely dispute the plan, without providing an exact timetable.
'I think we've been pretty clear from the outset that this is the first year of a multi-year process,' Scheer said as the PWHL
closes the final week of the regular season
. 'It could come in Year 4. It could come Year 5. I think that those conversations are still being had.'
Neutral site stops this past season in Denver, Detroit, Quebec City and Edmonton each topped 14,000 fans.
The new team will initially go by PWHL Seattle and its colors will be emerald green and cream. The team will play out of the NHL Kraken's Climate Pledge Arena and practice at the Kraken Community Iceplex. Vancouver also has not announced a nickname yet.
Though all PWHL teams are centrally controlled by the league, Seattle's expansion bid was led by the Kraken and the Oak View Group, which developed and operates Climate Pledge Arena.
Oak View has longtime ties to women's hockey, and expressed interest in landing an original six franchise when the league was established in June 2023 by Los Angeles Dodgers owner Mark Walter, his wife Kimbra, and tennis icon Billie Jean King.
Seattle features a growing youth hockey program, is home to the WNBA's Storm and NWSL's Reign, and previously shown support for women's hockey. In November 2022, Seattle drew a U.S.-Canada Rivalry Series record crowd of 14,551. In January, the PWHL drew a crowd of 12,608 in kicking off its nine-game Takeover Tour of neutral site games in Seattle.
Boston Fleet captain and four-time U.S. Olympian
Hilary Knight was a proponent of Seattle
in the weeks ahead of her team's Takeover Tour game against Montreal.
'I have yet to experience another crowd like that,' Knight said of the Rivalry Series game. 'Seattle holds a special place in my mind, and that's why I'm super excited to be able to share that experience with other teammates, whether it's on the Fleet or on the Montreal team.'
The PWHL plans to announce the date of an expansion draft and how Vancouver and Seattle will be integrated into its
entry draft on June 24
at a later time.
'Seattle is an incredible sports city and we've seen firsthand the passion for the women's game,' said Kraken owner Samantha Holloway. 'We're also proud to grow the game of hockey ... and together we'll continue to inspire the next generation of hockey players and fans alike.'
In the bigger picture, the PWHL's accelerated expansion plans coincide with wealth of college talent anticipated to enter the league over the next two years. The league's growth is also expected to lure more Europeans to North America.
'Upon launch, you've got six teams and maybe if you're not North American, you don't know really what to expect,' PWHL executive vice president of hockey operations Jayna Hefford said. 'Now I think these players are seeing that this league is here, it's thriving, it's growing, and they are going to want to be a part of it.'
In overseeing the expansion search, Scheer was impressed by the response.
'I feel more encouraged than ever about what our business looks like and what our business can be,' she said. 'As we look to expand and move beyond Year 3, we'll have plenty of suitors along the way as we look to grow.'
___
AP Women's Hockey:
https://apnews.com/hub/womens-hockey
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
an hour ago
- Yahoo
Eastern Libya Poised to Greenlight Turkish Offshore Exploration
Libya's eastern-based parliament is preparing to approve a 2019 maritime pact that would allow Turkey to explore for oil and gas in Libyan waters, according to people familiar with the talks in Benghazi and Ankara. Most obstacles to the accord have been cleared, they said, a striking reversal for the east—long aligned with commander Khalifa Haftar's Libyan National Army and historically opposed to Turkish involvement. Tripoli, which already maintains close ties with Ankara, backs the deal. If ratified, Turkish survey and drilling vessels could begin work in a corridor between Turkey and Crete, bolstering Ankara's claims in the eastern Mediterranean and likely aggravating disputes with Greece and Cyprus. The pending vote follows a cautious détente between Turkey and Haftar: a Turkish navy corvette, TCG K?nal?ada, is visiting Benghazi; Ankara is weighing military training support; and Haftar's son, Saddam, met Turkey's defense leadership in April. Turkey is also keen to revive billions of dollars in stalled construction contracts and has restarted direct flights to Benghazi, while major Turkish contractors scope reconstruction and materials production in the east. Eastern authorities increasingly see the accord as a way to attract investment. The maritime move comes as Libya's energy sector regains momentum. On August 19, the National Oil Corporation (NOC) reported over 1.38 million barrels of crude produced in the prior 24 hours, plus ~50,000 b/d of condensate and 2.48 bcf of natural gas, reaffirming its focus on production stability, domestic supply, and export obligations. Output reached a 12-year high of ~1.23 million b/d in May despite periodic clashes around Tripoli, and NOC targets 2 million b/d by 2028 through capacity expansions and stronger infrastructure. Libya launched its first field tenders in 17 years in March, drawing 400+ bids across 22 blocks, and ExxonMobil signed an MoU this month to assess offshore blocks off the northwest coast and the Sirte Basin—signals of returning foreign interest. Libya's light, low-sulfur barrels remain highly prized, with reserves leading Africa and ranking ninth globally. Regionally, the potential Turkish exploration underscores shifting geopolitics. With Russia preoccupied in Ukraine, Simon Watkins writes that Washington and London are pushing to cement influence across the Middle East and North Africa, backing economic stabilization tied to energy development in states like Syria and Libya. In Libya, BP and Shell recently signed frameworks with NOC to evaluate redevelopment of large onshore fields and other assets, while a Mellitah Oil & Gas–Hill International agreement aims to lift gas output from 2026. These moves—alongside U.S. and European engagement—make it harder for rivals to reassert dominance. Still, the maritime file is fraught. Greece in May tendered exploration blocks south of Crete that overlap waters Libya claims; the European Union has argued the mooted Libya–Turkey arrangement infringes third-state rights and conflicts with the UN Law of the Sea. For Libya, the near-term challenge is operational continuity: safeguarding fields and export terminals, ensuring power and water for upstream operations, and keeping cross-faction revenue disputes in check. If stability holds and planned investments proceed, Libya could add meaningful barrels just as global supply is expected to loosen into late 2025–2026—while Ankara's prospective offshore campaigns would add a new layer of complexity to the eastern Mediterranean energy map. By Charles Kennedy for More Top Reads From this article on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Kenneth Walker returns to Seahawks practice, for now; Tory Horton injury update
Kenneth Walker was back. Again. The Seahawks' lead running back's on-again, off-again training camp was back on Sunday morning. Walker was full go for the practice in shells, helmet and shorts. He ran with the ball and caught passes from quarterback Sam Darnold on the first-team offense in 11-on-11 scrimmaging. Walker has missed Seattle's bulldozing running and run-blocking by the offensive line in each of the team's first two preseason games. The Seahawks have run for 170 yards on the Raiders and 268 yards against the Chiefs. All those yards have been with Zach Charbonnet and George Holani as lead runners, not Walker. Walker's been sidelined for multiple-day stretches this month with what coach Mike Macdonald has described as a sore foot. Macdonald said following Walker's latest return to full duty the plan is for the lead rusher to be full go Thursday. That's when the Seahawks' starters practice against the Packers' starters in a joint practice in Green Bay. Walker missed six of 17 games last season. He finished the year on injured reserve with an ankle injury in December. He's yet to play a full 17-game season in any of his first three years in the NFL, since Seattle drafted him in the second round from Michigan State in 2022. The Seahawks held Walker out of offseason practices this spring. 'He looks great. He looks fast. He's hitting his targets, reading it out pretty well. It's exciting to have him out there, you know,' Macdonald said Sunday. 'When he's been out there, it's been pretty good.' When he's been out there. The Seahawks are into the final week of their preseason. There is a growing sense Walker needs to string together full-go practices to get a better feel for new offensive coordinator Klint Kubiak's and new line coach John Benton's outside-zone run-blocking scheme. The new system demands running backs have precise timing and synchronizing with the blockers at the assigned point of attack, at exactly the assigned time in the play. Macdonald was asked where he was in the balance of protecting Walker from more injuries with him needing to get practice repetitions full go before the opening game Sept. 7 against San Francisco. 'Yeah, it's a great question. It's a balance,' the head coach said. 'There's a lot of walk-through reps that need to be had. But at some point, to your point, you've got to do it on the field so that you feel confident here and execute at a high level and play your best football. 'That's something that we're working through.' Tory Horton update Tory Horton missed practice Sunday. He came out wearing his practice jersey over sweatpants and sneakers, not cleats, without his helmet. The rookie fifth-round draft choice from Colorado State watched Marquez Valdes-Scantling take his place as the third wide receiver in the starting offense during full-team scrimmaging later in the workout. Horton left the preseason game Friday against Kansas City and went into the locker room with what Macdonald said was an ankle injury. Sunday, all Macdonald specified about Horton's injury was that it was, again, 'an ankle.' Asked if the team believed it was a series injury, Macdonald said: 'Not to my knowledge.'
Yahoo
2 hours ago
- Yahoo
AAHI Partners with Quratis to Strengthen Global Vaccine Manufacturing and Accelerate Access to Lifesaving Vaccines
SEATTLE, August 21, 2025--(BUSINESS WIRE)--Access to Advanced Health Institute (AAHI), a global leader in translating high-impact science into scalable, field-ready vaccine solutions, today announced an exciting new partnership with Quratis, a premier biotechnology company and advanced Contract Development and Manufacturing Organization (CDMO). This collaboration marks a pivotal step forward in breaking through barriers in global health equity around the world. Under this strategic alliance, Quratis has been selected as AAHI's preferred manufacturer for high-quality pre-clinical and clinical vaccine supplies, with the capacity to expand into commercial-scale production for global markets. This collaboration will accelerate the development of AAHI's innovative vaccine candidates targeting deadly diseases such as tuberculosis, and of vaccines that rely on AAHI's vaccine adjuvants to provide protection against malaria, HIV, and other global health threats. Quratis brings a world-class GMP-certified bioplant and cutting-edge CDMO expertise in biopharmaceutical raw material development, process optimization, and finished pharmaceutical manufacturing. By designating Quratis as preferred partner, AAHI strengthens both its scientific capabilities and access to scalable, cost-effective production of its groundbreaking vaccine formulations—including dry vaccines that eliminate cold chain dependencies and needle-free delivery systems for superior respiratory protection. The partnership ensures a seamless supply chain platform, enabling swift clinical development and broader deployment to the world's most vulnerable populations. "Partnering with Quratis is a very important step in AAHI's strategy to advance practical, life-saving vaccines, that can be deployed at scale where they're needed most," said Keeley Foley, CEO of AAHI. "Quartis' innovative cutting edge, safe, world-class CDMO capabilities makes it possible for AAHI to deliver on our mission – and helps ensure our efforts to combat infectious diseases and foster health autonomy worldwide. Together, we're not just manufacturing vaccines—we're delivering an important mission to revolutionize global health." Quratis, renowned for its global innovation in healthcare, brings unparalleled expertise in vaccine development and manufacturing to the table. With a track record of success in TB and COVID-19 vaccines like QTP101 and QTP104, Quratis' advanced processes will enhance AAHI's pipeline, ensuring high-quality, efficient production from pre-clinical stages through clinical trials. "We are honored and thrilled to join forces with AAHI, a pioneer in immune-enhancing technologies and sustainable vaccine solutions," said Soung Joon Kim, CEO of Quratis. "This partnership aligns perfectly with our vision of making people happy and healthy through borderless healthcare innovations. By supporting AAHI's pipeline, we expect to create value not only for global health, but also for our shareholders through long-term growth opportunities." The partnership builds on existing collaborations, including the co-development of the ID93+GLA-SE tuberculosis vaccine candidate (QTP101), and underscores a shared commitment to strengthening international vaccine supply chains, advancing equitable access, and fostering worldwide manufacturing capacity for sustainable program deployment. For more information about this partnership or to explore collaboration opportunities, and order pre clinical materials please contact info@ About Access to Advanced Health Institute (AAHI) Access to Advanced Health Institute (AAHI) is a global leader in developing practical, cost-effective vaccines to combat deadly diseases such as tuberculosis, malaria, and HIV. With a mission to translate high-impact science into scalable, field-ready solutions, AAHI breaks through barriers in global health by creating innovative vaccine formulations, building worldwide manufacturing capacity, and fostering partnerships to ensure sustainable, equitable health outcomes. For more information, visit or contact us at info@ About Quratis Quratis Inc. is a leading biopharmaceutical company specializing in innovative vaccine development and advanced biologics manufacturing. With a state-of-the-art GMP facility and strong global partnerships, Quratis is at the forefront of developing next-generation vaccines against infectious diseases, including tuberculosis, COVID-19, schistosomiasis, and neglected tropical diseases. In addition to its core vaccine pipeline, Quratis offers superior CDMO capabilities, including expertise in mRNA–LNP drug delivery platforms that provide seamless bench-to-field support from research through commercial production. By combining cutting-edge R&D with scalable manufacturing, Quratis is committed to delivering high-quality, accessible, and life-saving solutions to patients worldwide. For more information, visit View source version on Contacts Casey Felipeinfo@ Sign in to access your portfolio